• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066].

作者信息

Sheffler Douglas J, Nedelcovych Michael T, Williams Richard, Turner Stephen C, Duerk Brittany B, Robbins Megan R, Jadhav Sataya B, Niswender Colleen M, Jones Carrie K, Conn P Jeffrey, Nathan Daniels R, Lindsley Craig W

机构信息

Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Apoptosis and Cell Death Research Program and Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Rd., La Jolla, CA 92037, USA.

Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

出版信息

Bioorg Med Chem Lett. 2017 May 1;27(9):2079. doi: 10.1016/j.bmcl.2017.03.046. Epub 2017 Mar 24.

DOI:
10.1016/j.bmcl.2017.03.046
PMID:28347668
Abstract
摘要

相似文献

1
Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066].
Bioorg Med Chem Lett. 2017 May 1;27(9):2079. doi: 10.1016/j.bmcl.2017.03.046. Epub 2017 Mar 24.
2
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteres.新型甘氨酸转运蛋白 1 抑制剂类结构化合物。第 2 部分：基于[3.3.0]桥环系列和其他哌啶类生物等排体的开发。
Bioorg Med Chem Lett. 2014 Feb 15;24(4):1062-6. doi: 10.1016/j.bmcl.2014.01.011. Epub 2014 Jan 13.
3
Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580].
Bioorg Med Chem Lett. 2020 Aug 15;30(16):127363. doi: 10.1016/j.bmcl.2020.127363. Epub 2020 Jun 23.
4
Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390].
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5353. doi: 10.1016/j.bmcl.2017.10.033. Epub 2017 Oct 27.
5
Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675].
Bioorg Med Chem Lett. 2020 Jan 15;30(2):126771. doi: 10.1016/j.bmcl.2019.126771. Epub 2019 Dec 16.
6
Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].《新型苯甲酰胺衍生物作为高效的Smoothened拮抗剂的合成及生物学评价》的勘误[《生物有机与药物化学快报》24/5 (2014) 1426 - 1431]
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4558. doi: 10.1016/j.bmcl.2015.06.051. Epub 2016 Aug 16.
7
Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].《新型查尔酮取代苯磺酰胺的合成及其碳酸酐酶抑制活性》的勘误 [《生物有机与药物化学快报》26 (2016) 5867 - 5870]
Bioorg Med Chem Lett. 2017 Aug 15;27(16):3944. doi: 10.1016/j.bmcl.2017.02.074. Epub 2017 Jul 10.
8
Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369].
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4386. doi: 10.1016/j.bmcl.2016.07.035. Epub 2016 Jul 26.
9
Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].《通过三组分反应合成新型抗癌钌-芳烃吡啶基亚甲基支架》的勘误 [《生物有机与药物化学快报》26 (2016) 2695-2700]
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4154-4155. doi: 10.1016/j.bmcl.2016.06.069.
10
Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
Bioorg Med Chem Lett. 2017 Jul 15;27(14):3205. doi: 10.1016/j.bmcl.2017.05.056. Epub 2017 May 24.